63.Suzuki K, Tanaka T, Enoki M, et al: Coordinated reassembly of the basement membrane and junctional proteins. Invest Ophthalmol Vis Sci 2000; 41:2495-2500.
64.Schermer A, Galvin S, Sun TT: Differentiation-related expression of a major 64K corneal keratin in vivo and in culture suggests limbal location of corneal epithelial stem cells. J Cell Biol 1986; 103:49-62.
65.Kurpakus MA, Stock EL, Jones JC: Expression of the 55-kD/64-kD corneal keratins in ocular surface epithelium. Invest Ophthalmol Vis Sci 1990; 31:448-456.
66.Nishida K, Honma Y, Dota A, et al: Isolation and chromosomal localization of a cornea-specific human keratin 12 gene and detection of four mutations in Meesmann corneal epithelial dystrophy. Am J Hum Genet 1997; 61:1268-1275.
67.Hacket DJ, Bakos I: Langerhans cells in the normal conjunctiva and peripheral cornea of selected species. Invest Ophthalmol Vis Sci 1981; 21:759-765.
68.Gillette TE, Chandler JW, Greiner JV: Langerhans cells of the ocular surface. Ophthalmology 1982; 89:700-710.
69.Rubsamen PE, McCulley J, Bergstresser PR, et al: On the Ia immunogenicity of mouse corneal allografts infiltrated with Langerhans cells. Invest Ophthalmol Vis Sci 1984; 25:513-518.
70.Whitsett CF, Stulting RD: The distribution of HLA antigens on human corneal tissue. Invest Ophthalmol Vis Sci 1984; 25:519-524.
71.Pfister RR: The normal surface of corneal epithelium: a scanning electron microscopic study. Invest Ophthalmol 1973; 12:654-668.
72.Argueso P, Gipson IK: Epithelial mucins of the ocular surface: structure, biosynthesis and function. Exp Eye Res 2001; 73:281-289.
73.Pflugfelder SC, Liu Z, Monroy D, et al: Detection of sialomucin complex (MUC4) in human ocular surface epithelium and tear fluid. Invest Ophthalmol Vis Sci 2000; 41:1316-1326.
74.Yokoi N, Kinoshita S: Clinical evaluation of corneal epithelial barrier function with the slit-lamp fluorophotometer. Cornea 1995; 14:485-489.
75.Gipson IK, Spurr-Michaud SJ, Tisdale AS: Anchoring fibrils form a complex network in human and rabbit cornea. Invest Ophthalmol Vis Sci 1987; 28:212-220.
76.Bentz H, Morris NP, Murray LW, et al: Isolation and partial characterization of a new human collagen with an extended triple-helical structural domain. Proc Natl Acad Sci USA 1983; 80:3166-3172.
77.Takahashi M, Fujimoto T, Honda Y, et al: Immunoelectron microscopy of E-cadherin in the intact and wounded mouse corneal epithelium. Acta Histochem Cytochem 1991; 24:619-623.
78.Hynes RO: Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110:673-687.
79.Nishida T, Nakagawa S, Watanabe K, et al: A peptide from fibronectin cell-binding domain inhibits attachment of epithelial cells. Invest Ophthalmol Vis Sci 1988; 29:1820-1825.
80.Paallysaho T, Williams DS: Epithelial cell-substrate adhesion in the cornea of actin, talin, integrin and fibronectin. Exp Eye Res 1991; 52:261-267.
81.Tervo K, Tervo T, van Setten G-B, et al: Integrins in human corneal epithelium. Cornea 1991; 10:461-465.
82.Lauweryns B, van den Oord JJ, Volpes R, et al: Distribution of very late activation integrins in the human cornea. An immunohistochemical study using monoclonal antibodies. Invest Ophthalmol Vis Sci 1991; 32:2079-2085.
83.Murakami J, Nishida T, Otori T: Coordinated appearance of β1 integrins and fibronectin during corneal wound healing. J Lab Clin Med 1992; 120:86-93.
84.Nishida T, Nakagawa S: Expression of fibronectin receptors in corneal epithelial cells. In: Beuerman RW, Crosson CE, Kaufman HE, ed. Healing processes in the cornea, The Woodlands, TX: Portfolio Publishing Co.; 1989:127-135.
85.Watson PG, Young RD: Scleral structure, organisation and disease. A review. Exp Eye Res 2004; 78:609-623.
86.Ueda A, Nishida T, Otori T, et al: Electron-microscopic studies on the presence of gap junctions between corneal fibroblasts in rabbits. Cell Tissue Res 1987; 249:473-475.
87.Nishida T, Yasumoto K, Otori T, et al: The network structure of corneal fibroblasts in the rat as revealed by scanning electron microscopy. Invest Ophthalmol Vis Sci 1988; 29:1887-1890.
88.Tomasek JJ, Gabbiani G, Hinz B, et al: Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 2002; 3:349-363.
89.Toris CB, Gabelt BT, Kaufman PL: Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction. Surv Ophthalmol 2008; 53(suppl 1):S107-S120.
90.Otori T: Electrolyte content of rabbit corneal stroma. Exp Eye Res 1967; 6:356-367.
91.Dodson JW, Hay ED: Secretion of collagen by corneal epithelium. II. Effect of the underlying substratum on secretion and polymerization of epithelial products. J Exp Zool 1974; 189:51-72.
92.Linsenmayer TF, Fitch JM, Mayne R: Extracellular matrices in the developing avian eye: type V collagen in corneal and noncorneal tissues. Invest Ophthalmol Vis Sci 1984; 25:41-47.
93.Fitch JM, Gross J, Mayne R, et al: Organization of collagen type I and V in the embryonic chicken cornea: monoclonal antibody studies. Proc Natl Acad Sci USA 1984; 81:2791-2795.
94.Konomi H, Hayashi T, Nakayasu K, et al: Localization of type V collagen and type IV collagen in human cornea, lung, and skin. Immunohistochemical evidence by anti-collagen antibodies characterized by immunoelectroblotting. Am J Pathol 1984; 116:417-426.
95.Birk DE, Fitch JM, Linsenmayer TF: Organization of collagen type I and V in the embryonic chicken cornea. Invest Ophthalmol Vis Sci 1986; 27:1470-1477.
96.Yue BYJT, Sugar J, Schrode K: Collagen staining in corneal tissues. Curr Eye Res 1986; 5:559-564.
97.McLaughlin JS, Linsenmayer TF, Birk DE: Type V collagen synthesis and deposition by chicken embryo corneal fibroblasts in vitro. J Cell Sci 1989; 94:371-379.
98.Kern P, Menasche M, Robert L: Relative rates of biosynthesis of collagen type I, type V and type VI in calf cornea. Biochem J 1991; 274:615-617.
99.Komai Y, Ushiki T: The three-dimensional organization of collagen fibrils in the human cornea and sclera. Invest Ophthalmol Vis Sci 1991; 32:2244-2258.
100.Doane KJ, Yang G, Birk DE: Corneal cell-matrix interactions: Type VI collagen promotes adhesion and spreading of corneal fibroblasts. Exp Cell Res 1992; 200:490-499.
101.Giraud JP, Pouliquen Y, Offret G, et al: Statistical morphometric studies in normal human and rabbit corneal stroma. Exp Eye Res 1975; 21:221-229.
102.Hamada R, Pouliquen Y, Giranud JP, et al: Quantitative analysis on the ultrastructure of human fetal cornea. In: Yamada E, Mishima S, ed. The structure of the eye III, Tokyo: Jpn J Ophthalmol; 1976:49-62.
103.Hamada R, Giraud JP, Graf B, et al: Etude analytique et statistique des lamelles, des keratocytes, des fibrilles de collagene de la region centrale de la cornee humaine normale. [Analytical and statistical study of the lamellae, keratocytes and collagen fibrils of the central region of the normal human cornea (light and electron microscopy).]. Arch Ophtalmol Rev Gen Ophtalmol 1972; 32:563-570.
104.Ihanamaki T, Pelliniemi LJ, Vuorio E: Collagens and collagen-related matrix components in the human and mouse eye. Prog Retin Eye Res 2004; 23:403-434.
105.Iozzo RV: Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67:609-652.
106.Funderburgh JL: Keratan sulfate: structure, biosynthesis, and function. Glycobiology 2000; 10:951-958.
107.Funderburgh JL, Corpuz LM, Roth MR, et al: Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J Biol Chem 1997; 272:28089-28095.
108.Liu CY, Shiraishi A, Kao CW, et al: The cloning of mouse keratocan cDNA and genomic DNA and the characterization of its expression during eye development. J Biol Chem 1998; 273:22584-22588.
109.Kao WW, Liu CY: Roles of lumican and keratocan on corneal transparency. Glycoconj J 2002; 19:275-285.
110.Liu CY, Birk DE, Hassell JR, et al: Keratocan-deficient mice display alterations in corneal structure. J Biol Chem 2003; 278:21672-21677.
111.Pellegata NS, Dieguez-Lucena JL, Joensuu T, et al: Mutations in KERA, encoding keratocan, cause cornea plana. Nat Genet 2000; 25:91-95.
112.Chakravarti S, Magnuson T, Lass JH, et al: Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998; 141:1277-1286.
113.Saika S, Shiraishi A, Liu CY, et al: Role of lumican in the corneal epithelium during wound healing. J Biol Chem 2000; 275:2607-2612.
114.Danielson KG, Baribault H, Holmes DF, et al: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997; 136:729-743.
115.Paluru PC, Scavello GS, Ganter WR, et al: Exclusion of lumican and fibromodulin as candidate genes in MYP3 linked high grade myopia. Mol Vis 2004; 30:917-922.
116.Johnson DH, Bourne WM, Campbell RJ: The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas. Arch Ophthalmol 1982; 100:1942-1947.
117.Fitch JM, Birk DE, Linsenmayer C, et al: The spatial organization of Descemet's membrane-associated type IV collagen in the avian cornea. J Cell Biol 1990; 110:1457-1468.
118.Suda T, Nishida T, Ohashi Y, et al: Fibronectin appears at the site of corneal stromal wound in rabbits. Curr Eye Res 1981; 1:553-556.
119.Fujikawa LS, Foster CS, Harrist TJ, et al: Fibronectin in healing rabbit corneal wounds. Lab Invest 1981; 45:120-129.
120.Bourne WM, Johnson DH, Campbell RJ: The ultrastructure of Descemet's membrane. III. Fuchs’ dystrophy. Arch Ophthalmol 1982; 100:1952-1955.